The Centers for Medicare and Medicaid Services confirmed July 28 that it will end the Part D Premium Stabilization Demonstration after 2026 — a $3.6 billion-a-year payment to insurers, launched in 2025, that has been holding down stand-alone drug plan premiums. [1] The Wall Street Journal broke the decision; Reuters confirmed it with the agency. [1] [2] What ends is the demonstration. What does not end is Medicare Part D, and what does not end is Extra Help, the low-income subsidy. [3]
That separation is the entire service story, and it needed a news organization to state it because the viral frame did not. USA Today's July 30 explainer exists precisely to correct the version that traveled — that Medicare drug subsidies were ending outright. [3] For the roughly 25 million people enrolled in stand-alone prescription drug plans, the difference between a subsidy expiring and a program ending is the difference between a higher bill and no bill to pay at all.
What the demonstration was
The Premium Stabilization Demonstration began in 2025, after the drug-benefit redesign capped out-of-pocket spending and reshuffled who bore the plan's costs. Insurers facing the new liability bid premiums up; the demonstration paid them to bid down instead, buying premium calm at $3.6 billion a year. [1] It was a stabilization program in the literal sense — a payment intended to keep a redesigned market quiet while it settled. Ending it after 2022-style debates about whether the money bought stability or merely delayed the invoice is precisely the argument now arriving, except the invoice goes to enrollees.
What the record actually says
The confirmed facts fit in a paragraph. The demonstration ends after 2026. The 2027 national base beneficiary premium is $41.33. [2] No 2027 plan-level premium exists yet — insurers file their bids, and the plans arrive in the fall. Everything beyond that is forecast. Dr. Mehmet Oz, the CMS administrator, says premiums will rise less than $10 for most beneficiaries. That is his claim, published alongside the announcement, and it will survive or die on the rate filings. [2]
The premium-rise frame the Journal and Reuters carry is a forecast too — a well-sourced one, grounded in what the demonstration was spending, but a forecast. The demonstration paid insurers to keep bids low; removing the payment returns plans to market pricing; market pricing on a book that includes GLP-1 drugs and specialty therapies points up. The direction is reasonable to expect. The amount is not yet knowable, and any outlet that printed one printed ahead of the bids.
What an enrollee should actually do
For the reader holding a Part D card, the actionable record is smaller than the political one. Nothing changes in 2026. Notices and plan documents arrive in the fall; open enrollment follows; the base premium and the plan premium are different numbers, and only the first exists today. Extra Help — the low-income subsidy that covers premiums and cost-sharing for those who qualify — does not change with the demonstration's sunset, and enrollees near the income thresholds would be served by checking it rather than by absorbing a viral headline. [3] Medicare Advantage plans with built-in drug coverage are a separate market with a separate premium logic; the sunset lands on stand-alone plans specifically.
One more distinction protects the reader. The demonstration paid insurers, not people — no enrollee ever saw a line item for it — which is why its ending feels like something being taken away that was never visibly given. The premium it suppressed is real; the subsidy on the bill never existed.
The confusion itself is worth a moment's attention, because it was not random. A subsidy with stabilization in its name, aimed at insurers and invisible on any individual bill, is nearly impossible for a beneficiary to picture. Programs that end without ever having been seen end loudly. The demonstration was designed to be unnoticed, and it succeeded — until its absence became the story.
The test date
The honest service frame is a calendar. Fall rate filings will show plan by plan what the sunset costs; the "less than $10" claim will meet its evidence there, and so will the premium-rise forecasts. Between now and then, the verified record is a $3.6 billion payment ending, a $41.33 base premium, and 25 million people whose correct next step is to read a letter that has not been mailed yet. [1] [2] The gap between the panic and the paperwork is where this story lives, and it closes in the fall, one filing at a time.
-- NORA WHITFIELD, Chicago